相似文献
1
Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice.
Antimicrob Agents Chemother. 1982 Jan;21(1):44-50. doi: 10.1128/AAC.21.1.44.
2
Optimal treatment of herpes simplex virus encephalitis in mice with oral acyclovir.
Am J Med. 1982 Jul 20;73(1A):125-31. doi: 10.1016/0002-9343(82)90077-8.
3
Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy.
Antimicrob Agents Chemother. 1982 May;21(5):744-52. doi: 10.1128/AAC.21.5.744.
4
Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients.
Ann Intern Med. 1982 Mar;96(3):270-7. doi: 10.7326/0003-4819-96-3-270.
5
Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells.
Biochem Pharmacol. 1985 Apr 1;34(7):1049-56. doi: 10.1016/0006-2952(85)90608-2.
6
Neonatal acyclovir pharmacokinetics in patients with herpes virus infections.
Am J Med. 1982 Jul 20;73(1A):210-4. doi: 10.1016/0002-9343(82)90093-6.
7
Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.
J Gen Virol. 1981 Oct;56(Pt 2):259-65. doi: 10.1099/0022-1317-56-2-259.
8
Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice.
Am J Med. 1982 Jul 20;73(1A):96-9. doi: 10.1016/0002-9343(82)90072-9.
9
Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
Antimicrob Agents Chemother. 1981 May;19(5):937-9. doi: 10.1128/AAC.19.5.937.
10
Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
Am J Med. 1982 Jul 20;73(1A):138-42. doi: 10.1016/0002-9343(82)90079-1.
引用本文的文献
1
N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigs.
Antiviral Res. 2011 Nov;92(2):386-8. doi: 10.1016/j.antiviral.2011.08.021. Epub 2011 Sep 7.
2
Fluorescent xDNA nucleotides as efficient substrates for a template-independent polymerase.
Nucleic Acids Res. 2011 Mar;39(4):1586-94. doi: 10.1093/nar/gkq853. Epub 2010 Oct 14.
3
Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs.
Neuroscience. 2007 Feb 23;144(4):1495-508. doi: 10.1016/j.neuroscience.2006.11.029. Epub 2006 Dec 29.
4
Herpesviruses--a rationale for antiviral treatment in multiple sclerosis.
Antiviral Res. 1999 Feb;41(1):1-19. doi: 10.1016/s0166-3542(98)00067-9.
5
Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.
Antimicrob Agents Chemother. 1983 Jul;24(1):95-103. doi: 10.1128/AAC.24.1.95.
6
Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
Drugs. 1983 Nov;26(5):378-438. doi: 10.2165/00003495-198326050-00002.
7
Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice.
Antimicrob Agents Chemother. 1984 Oct;26(4):557-62. doi: 10.1128/AAC.26.4.557.
8
Drug combinations for treatment of mice infected with acyclovir-resistant herpes simplex virus.
Antimicrob Agents Chemother. 1987 Mar;31(3):477-9. doi: 10.1128/AAC.31.3.477.
9
Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
Antimicrob Agents Chemother. 1986 Jan;29(1):77-84. doi: 10.1128/AAC.29.1.77.
10
Trifluorothymidine: potential non-invasive diagnosis of herpes simplex infection using 19F nuclear magnetic resonance in a murine hepatitis model.
J Virol Methods. 1987 Dec;18(4):257-69. doi: 10.1016/0166-0934(87)90087-5.
本文引用的文献
1
In vitro susceptibility of varicella-zoster virus to acyclovir.
Antimicrob Agents Chemother. 1980 Sep;18(3):443-7. doi: 10.1128/AAC.18.3.443.
2
Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase.
J Biol Chem. 1980 Aug 10;255(15):7204-7.
3
A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine].
Anal Biochem. 1979 Oct 1;98(2):319-28. doi: 10.1016/0003-2697(79)90148-9.
4
The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent.
J Antimicrob Chemother. 1979 Jul;5(4):431-6. doi: 10.1093/jac/5.4.431.
5
Therapy of experimental herpes simplex encephalitis with aciclovir in mice.
Antimicrob Agents Chemother. 1979 Jun;15(6):775-9. doi: 10.1128/AAC.15.6.775.
6
Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.
J Virol. 1979 Oct;32(1):72-7. doi: 10.1128/JVI.32.1.72-77.1979.
7
Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.
Antimicrob Agents Chemother. 1979 May;15(5):723-9. doi: 10.1128/AAC.15.5.723.
8
9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.
Nature. 1978 Apr 13;272(5654):583-5. doi: 10.1038/272583a0.
9
Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid.
Antimicrob Agents Chemother. 1978 Jan;13(1):53-60. doi: 10.1128/AAC.13.1.53.
10
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716-20. doi: 10.1073/pnas.74.12.5716.
Zotero 插件